Marijuana-derived drug for epilepsy gets FDA committee recommendation


Recommended Posts

A US Food and Drug Administration advisory committee on Thursday unanimously recommended approval of an epilepsy drug that would be the first plant-derived cannabidiol medicine for prescription use in the United States.

 

The FDA will vote in June whether to approve the drug, Epidiolex, an oral solution, for the treatment of severe forms of epilepsy in a small group of patients. The FDA has approved synthetic versions of some cannabinoid chemicals found in the marijuana plant for other purposes, including cancer pain relief.

 

Cannabidiol, also called CBD, is one of more than 80 active cannabinoid chemicals, yet unlike tetrahydrocannabinol, or THC, it does not produce a high.

 

The committee's recommendation was delivered after reviewing data from the drug's maker, GW Pharmaceuticals PLC, a UK-based biopharmaceutical company.

 

"We're obviously very pleased by the unanimous recommendation in support of the approval of Epidiolex," GW CEO Justin Gover said. "It's a very important milestone in the approval process."

 

 

More....

https://www.cnn.com/2018/04/19/health/fda-committee-marijuana-drug-epilepsy-bn/index.html

Link to comment
Share on other sites

  • 2 months later...
This topic is now closed to further replies.